4//SEC Filing
Sakiris Spiro Kevin 4
Accession 0001493152-22-036385
CIK 0001725430other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 6:06 AM ET
Size
10.2 KB
Accession
0001493152-22-036385
Insider Transaction Report
Form 4
Sakiris Spiro Kevin
Chief Financial Officer
Transactions
- Purchase
Series D Convertible Preferred Stock
2022-12-22$0.87/sh+15,992$13,913→ 15,993 total(indirect: Held by Anest Holdings)→ Common Stock (15,993 underlying) - Purchase
Common Stock Purchase Warrant
2022-12-22$0.13/sh+47,979$6,079→ 47,979 total(indirect: Held by Anest Holdings)Exercise: $0.29From: 2023-06-23Exp: 2028-06-23→ Common Stock (47,979 underlying)
Holdings
- 125,228
Common Stock - Prior Balance
Footnotes (4)
- [F1]The Series D Convertible Preferred Stock is initially convertible into three shares of common stock of the Issuer. The conversion ratio is subject to adjustment. Following the Trigger Date (defined below), each share of Series D Convertible Preferred Stock is convertible at any time at the option of the holder and without payment of further consideration. The Series D Convertible Preferred Stock has no expiration date. As used herein, "Trigger Date" means the earlier to occur of (i) the date that the last of (a) the Issuer's shareholders approve the conversion of the Series D Convertible Preferred Stock or (b) the Issuer's shareholders approve a reverse split of the Issuers's common stock, or (ii) the date which is 60 days following the date on which the Common Stock is no longer listed on the Nasdaq Stock Market, the New York Stock Exchange or the NYSE American.
- [F2]On December 22, 2022, Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund, purchased 15,993 units from the Issuer in a private placement. Each unit consists of one share of Series D Convertible Preferred Stock (valued at $0.87 each) and three common stock purchase warrants (collectively valued at $0.35, or $0.1267 each). The purchase price of each unit was $1.25 per unit.
- [F3]These securities are held by Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund, of which Mr. Sakiris is a Director.
- [F4]Subject to adjustment.
Documents
Issuer
INTELLIGENT BIO SOLUTIONS INC.
CIK 0001725430
Entity typeother
Related Parties
1- filerCIK 0001830957
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 6:06 AM ET
- Size
- 10.2 KB